Hiberix

Hiberix

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Haemophilus influenzae type b (HIB) vaccine
Indications/Uses
Active immunisation of all infants ≥6 wk against disease caused by HIB.
Dosage/Direction for Use
IM Primary vaccination 3 doses in 1st 6 mth of life & may be started from 6 wk of age. Booster dose Recommended in 2nd yr of life. Previously unvaccinated infant 6-12 mth 2 inj at 1 mth-interval, followed by booster dose in 2nd yr of life. Previously unvaccinated childn 1-5 yr 1 dose.
Contraindications
Hypersensitivity to vaccine or after previous inj.
Special Precautions
Not to be inj IV. Not as substitute for routine tetanus vaccination. Not for protection against disease due to other types of H influenzae nor against meningitis caused by other organisms. Postpone vaccination in subjects w/ acute severe febrile illness. Syncope. Administer SC in patients w/ thrombocytopenia or bleeding disorders. Resp monitoring for 48-72 hr in very premature infants (≤28 wk of gestation) & w/ previous history of resp immaturity.
Adverse Reactions
Loss of appetite; crying, irritability, restlessness; somnolence; diarrhoea; fever, inj site swelling, pain & redness. Vomiting.
Drug Interactions
Adequate response may not be achieved w/ immunosuppressants.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07AG51 - haemophilus influenzae B, combinations with toxoids ; Belongs to the class of hemophilus influenzae B vaccines.
J07AG - Haemophilus influenzae B vaccines ; Used for active immunizations.
Presentation/Packing
Form
Hiberix vaccine 0.5 mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in